Thursday, 1 August 2013

Strides Arcolab receives approval from USFDA for Tenofovir Disoproxil Fumarate and Emtricitabine Tablets

Strides Arcolab Ltd has informed BSE regarding a Press Release dated August 01, 2013, titled "Strides Arcolab receives ANDA approval from USFDA for Tenofovir Disoproxil Fumarate and Emtricitabine Tablets" Strides Arcolab has received tentative approval from the USFDA for its anti aids combination drug Tenofovir Disoproxil Fumarate and Emtricitabine Tablets, 300mg and 200mg.

No comments:

Post a Comment